CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-07-23. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 1477 · Search date 2026-07-23 · Methodology v1.0

Myers' cocktail,
does it really help with Improved fatigue, pain, and quality of life in fibromyalgia and chronic-fatigue patients?

30-Second Summary
D
Evidence Grade D · 28 · Safety caution
The small placebo-controlled trial did not outperform the intravenous fluid placebo
There are risks of intravenous infection, phlebitis, electrolyte abnormalities, and out-of-pocket cost.
What the
research shows
Myers' cocktail is rated D. A double-blind randomized pilot trial in 34 adults compared weekly intravenous micronutrients with lactated Ringer's solution for eight weeks. Both groups improved from baseline, but there was no significant between-group difference. Because a placebo-controlled human trial exists, this is D for failure to demonstrate benefit over placebo rather than ? for absence of evidence.
What the
ads claim
Marketing equates intravenous delivery of vitamins and magnesium with rapid restoration of energy, pain relief, and immune recovery. The direct randomized trial did not show a specific benefit beyond the fluid placebo.
*

Useful facts when choosing a product

  • Myers' cocktail is not one standardized drug; it is a mixture of B vitamins, vitamin C, magnesium, and sometimes other ingredients whose composition and doses can differ among clinics.
  • Intravenous treatment carries risks of infection, bleeding, bruising, phlebitis, and infiltration. Rapid magnesium administration or impaired renal function can add hypotension and electrolyte risks.
  • Medical replacement of a documented deficiency should be distinguished from an evidence-uncertain wellness infusion, which also carries out-of-pocket cost and repeated-procedure burden.
  • Unlike verdict 1429 on injectable fursultiamine, this is a combined intravenous nutrient procedure with a placebo-controlled randomized trial; the appropriate grade is D rather than ?.
ID

Chamgap Semantic Classification Code

Candidate index · review held

UNK.myers-cocktail.intravenous.fatigue-pain-and-quality-of-life-in-fibromyalgia-and-chronic-fatigue-patients.improve.placebo

Unknown > Myers' cocktail > Intravenous > fatigue, pain, and quality of life in fibromyalgia and chronic-fatigue patients > Improvement claim > Placebo

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 1477 · D 28
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Ali and colleagues randomized 40 adults (34 analyzed) meeting American College of Rheumatology fibromyalgia criteria to intravenous micronutrients or lactated Ringer's placebo under double masking. Improvements within the Myers' group during eight weeks of treatment and follow-up did not translate into statistically significant superiority over placebo. The study is direct and controlled but was a pilot and did not separately recruit a chronic-fatigue-syndrome population. It therefore cannot establish improvement in fatigue, pain, or quality of life in fibromyalgia or broader chronic-fatigue populations.

02

Why this is classified as D (28)

In a 34-participant double-blind randomized trial, both groups improved, but Myers' cocktail was not significantly superior to lactated Ringer's placebo for fatigue, pain, or quality of life. Direct placebo-controlled failure and no confirmatory trial yield D with 28 points.

Counterpoint. Documented deficiency or dehydration warrants cause-specific treatment, but benefit from such treatment cannot be generalized to a fibromyalgia-specific effect of Myers' cocktail.

Rejudgment record. New verdict — Rated placebo-controlled efficacy as negative because the randomized double-blind trial in 34 adults found improvements in both the intravenous micronutrient and lactated Ringer's groups but no significant between-group difference in fatigue, pain, or quality of life

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduced fatigueDThe small randomized trial found no significant specific benefit over Ringer's placebo.
Reduced painDWithin-group improvement occurred, but there was no significant difference from placebo.
Improved quality of lifeDSuperiority over placebo was not demonstrated and no confirmatory trial is available.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Ali A et al. 2009Randomized double-blind lactated-Ringer's-placebo-controlled pilot trial34Supported by the United States NCCAM; some study materials were donatedTender points, pain, fatigue, depression, and quality of lifeBoth groups improved from baseline over eight weeks, but there was no significant difference between Myers' cocktail and lactated Ringer's placebo.Only key direct randomized trial
ClinicalTrials.gov NCT00067405Prospectively registered randomized double-blind clinical-trial record34National Center for Complementary and Integrative HealthFibromyalgia symptoms and feasibility and safety of intravenous micronutrientsConfirms the trial and design but is not an independent additional efficacy study.Registration cross-check
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-23).

Ali A, Njike VY, Northrup V, et al. Intravenous micronutrient therapy (Myers' Cocktail) for fibromyalgia: a placebo-controlled pilot study. J Altern Complement Med. 2009;15(3):247-257. PMID: 19250003. PMCID: PMC2894814. DOI: 10.1089/acm.2008.0410.
checked
ClinicalTrials.gov. Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia. NCT00067405. PMID: none. DOI: none.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-07-23 · Corrections: none

Cite this verdict

Myers' cocktail x improved fatigue, pain, and quality of life in fibromyalgia and chronic fatigue Evidence Grade D card
[Chamgap] Myers' cocktail x improved fatigue, pain, and quality of life in fibromyalgia and chronic fatigue — Evidence Grade D·28. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/energy/myers-cocktail-fibromyalgia-fatigue-pain-quality-of-life/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.